CTI Clinical Trials

CTI Clinical Trials

@CTIClinical

Followers3.8K
Following2.9K

CTI Clinical Trial & Consulting Services is a leading clinical research organization providing the full range of services for all stages of clinical development

Cincinnati, Ohio
Joined on April 19, 2011
Statistics

We looked inside some of the tweets by @CTIClinical and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
a day
Average replies
0
Average retweets
1
Average likes
3
Tweets with photos
45 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100

Rankings (sorted by number of followers)

30. globally and in category Science

148. in category Science

Today at noon, @917wvxu will be re-airing our CEO's interview in which he discusses this region's potential to bring a COVID-19 vaccine to the public! To learn more about volunteering for upcoming vaccine studies, visit https://t.co/nUXkZR0Wh6 https://t.co/qTZ7XCp0vD

While a good portion of our work recently shifted focus to COVID-19, we are thankful for our talented, flexible team that was able to keep our other trials moving forward in order to advance treatments for those that are chronically and critically ill! https://t.co/2woCZYEncQ

The @EMA_News has recommended granting conditional marketing authorization for imlifidase! This treatment is designed to help those with extremely high antibody levels that are often overlooked as a good match for a kidney transplant. https://t.co/xib9VJEg62

Congratulations to our friends and partners at @GravityCLIALab on the recent additions to their leadership team! They have grown exponentially over the last few months and hope to continue expanding with the expertise of their newest team members. https://t.co/q3z42KEmMF

Thank you to Anna Knierim , Pre-Press at @KahnyPrinting, for helping us get one step closer to bringing a COVID-19 vaccine to the public!

If you would like to join Anna in combating this virus, visit
https://t.co/MC08035sJ3

#COVIDvaccine #Volunteer #ClinicalResearch #COVID19 https://t.co/qftdlemfBn

Thank you to Anna Knierim , Pre-Press at @KahnyPrinting, for helping us get one step closer to bringing a COVID-19 vaccine to the public! If you would like to join Anna in combating this virus, visit https://t.co/MC08035sJ3 #COVIDvaccine #Volunteer #ClinicalResearch #COVID19 https://t.co/qftdlemfBn

We are thrilled to have been named Champion in multiple categories of the 2020 CRO Leadership Awards, and the only CRO named as Champion in the Quality category!

https://t.co/1yB5G0C1rn
Life Science Leader
@ClinicalLeader1  @ISRreports https://t.co/RjZCLGC2NI

We are thrilled to have been named Champion in multiple categories of the 2020 CRO Leadership Awards, and the only CRO named as Champion in the Quality category! https://t.co/1yB5G0C1rn Life Science Leader @ClinicalLeader1 @ISRreports https://t.co/RjZCLGC2NI

Thank you to Jeremy Schrand, Director of Marketing & Communications at NKY Chamber of Commerce, for helping us get one step closer to bringing a #COVID19vaccine to the public! 

To find out more and to join Jeremy, visit https://t.co/MC08035sJ3 https://t.co/457Q6gOuxP

Thank you to Jeremy Schrand, Director of Marketing & Communications at NKY Chamber of Commerce, for helping us get one step closer to bringing a #COVID19vaccine to the public! To find out more and to join Jeremy, visit https://t.co/MC08035sJ3 https://t.co/457Q6gOuxP

You can now listen to our CEO's @917wvxu interview with @MicMonksMedia in which he discusses how this region's collaborative efforts are making a global impact on COVID19! @ProcterGamble @kroger @GravityCLIALab @Meridian_Bio Bioscience @PPDCRO Medpace https://t.co/qTZ7XCp0vD

CTI will be a part of the virtual German Corona Showcase meeting this week! If you would like to set up a time to talk with our team about the #COVID19 pandemic and the work we are doing, send us a dm.
@BIODeutschland https://t.co/mxjzvCDw8d

CTI will be a part of the virtual German Corona Showcase meeting this week! If you would like to set up a time to talk with our team about the #COVID19 pandemic and the work we are doing, send us a dm. @BIODeutschland https://t.co/mxjzvCDw8d

Quoted @DePaulCristoRey

The partnership of our business community is critical to DPCR's success, so it’s inspiring to hear our Corporate Partners say they’re all in. https://t.co/m3adRNlz7A @kroger @mercy_health @CRarchitecture @ERSCincy @CTIClinical @messerwearebldg @fhlbcin @MountStJosephU

We are proud to be ALL IN! The @DePaulCristoRey students are an important part of our team and we are looking forward to having them back this fall. https://t.co/wDjzuy4sVY

Today at noon, our CEO will be on air with @MicMonksMedia, host of Cincinnati Edition on @917wvxu, to discuss how he believes this region has the potential to bring a COVID-19 vaccine to the public! For more details, visit https://t.co/qTZ7XCp0vD #COVIDVACCINE #NKY #Cincinnati

Our CEO was proud to be the first to sign up as a volunteer for our upcoming COVID-19 vaccine studies! 

If you would like to join Tim and help us bring a vaccine to the public, visit https://t.co/MC08035sJ3 

#COVID19 #COVIDvaccine #ClinicalResearch #Volunteer https://t.co/0qwIDtJynA

Our CEO was proud to be the first to sign up as a volunteer for our upcoming COVID-19 vaccine studies! If you would like to join Tim and help us bring a vaccine to the public, visit https://t.co/MC08035sJ3 #COVID19 #COVIDvaccine #ClinicalResearch #Volunteer https://t.co/0qwIDtJynA

We are thrilled to announce the addition of Sandra Miller to our data management team as well as the promotion of Jamie Meisenhelder to Director, Legal Affairs!

https://t.co/Z6ISJ4Qftn https://t.co/xa2z8NgFPn

We are thrilled to announce the addition of Sandra Miller to our data management team as well as the promotion of Jamie Meisenhelder to Director, Legal Affairs! https://t.co/Z6ISJ4Qftn https://t.co/xa2z8NgFPn

Our CEO, Tim Schroeder, is a guest on today's @nkychamber NKY Spotlight Podcast! He will be discussing all things COVID-19 and how this region is tackling the current pandemic. The Facebook live event will begin at 4 PM on the Chamber's page. https://t.co/9EmZGCeJy1

Thank you to Eric Thompson, Development Officer at Xavier University, for helping us get one step closer to bringing a COVID-19 vaccine to the public!

To find out more about our upcoming studies and to join Eric as a volunteer, visit
https://t.co/MC08035sJ3 https://t.co/hz3rdpkayI

Thank you to Eric Thompson, Development Officer at Xavier University, for helping us get one step closer to bringing a COVID-19 vaccine to the public! To find out more about our upcoming studies and to join Eric as a volunteer, visit https://t.co/MC08035sJ3 https://t.co/hz3rdpkayI

Thank you to @KMKLaw for helping us in our mission to recruit COVID-19 vaccine volunteers! To find out more, visit https://t.co/vAzA0rWmEN https://t.co/H8HrwclKTL

Thank you to @KMKLaw for helping us in our mission to recruit COVID-19 vaccine volunteers! To find out more, visit https://t.co/vAzA0rWmEN https://t.co/H8HrwclKTL

The data from the first clinical trial using @humanigen Lenzilumab in high-risk #COVID19 patients came back with promising results! This treatment showed a rapid recovery in patients and lead to their discharge after a median of 5 days. https://t.co/WqFipNoxpx

Thank you to @LeeCrume, President and CEO of @NKYTriED, for helping us get one step closer to bringing a COVID-19 vaccine to the public!

To find out more about our upcoming studies and to volunteer, visit https://t.co/MC08035sJ3 https://t.co/c5whcVLleg

Thank you to @LeeCrume, President and CEO of @NKYTriED, for helping us get one step closer to bringing a COVID-19 vaccine to the public! To find out more about our upcoming studies and to volunteer, visit https://t.co/MC08035sJ3 https://t.co/c5whcVLleg

The @HorizonCFNKY has distributed over $550,000 through their Coronavirus Relief Fund since its inception! Now, with assistance from @LifeLearningCtr this relief fund will deploy $50,000 for PPE equipment which will be distributed to local nonprofits. https://t.co/VUEVjVrASz

Quoted @achillestx

Our CEO and co-founders share their excitement following the dosing of the first melanoma patient in a phase I/II study using Achilles’ proprietary clonal neoantigen T cell (cNeT) therapy. Watch the video here: https://t.co/GGjzaBsaU1 #clonalneoantigens #immunooncology #biotech

Congratulations to our friends and partners at @achillestx on dosing their first melanoma patient! https://t.co/h91XJEfTyU

Next Page